Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jonathan Lord

Premium

Jonathan Lord has been named to Vigilant Biosciences' board of directors. Lord was previously CEO at Navigenics and currently serves as the chair of the board of directors of Dexcom, director at Stericycle, and on the advisory board of Serco, Anthello Health, and Third Rock Ventures.

Additionally, he is chief operating officer of the University of Miami's Miller School of Medicine and a professor of pathology.

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.